[1]
|
T. Welton, “Room-Temperature Ionic Liquids: Solvents for Synthesis and Catalysis,” Chemical Reviews, 1999, p. 2701. doi:10.1021/cr1003248
|
[2]
|
P. Wasserschid and W. Keim, “Ionic Liquids—New ‘Solutions’ for Transition Metal Catalysis,” Angewandte Chemie International Edition, Vol. 39, No. 21, 2000, pp. 3772-3789.
doi:10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5
|
[3]
|
R. Sheldon, “Catalytic Reactions in Ionic Liquids,” Chemical Communications, No. 23, 2001, pp. 2399-2407.
doi:10.1039/b107270f
|
[4]
|
R. T. Coutts and A. F. Casay, “Pyridine and Its Derivatives: A Supplement,” Inter Science Publishers, New York, 1975.
|
[5]
|
M. Ferles and J. Pliml, “Adavances in Heterocyclic Chemistry,” Academic Press, New York, 1970.
|
[6]
|
J. W. Langston, P. Ballard, J. W. Tetrud and I. Irwin, “Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis,” Science, Vol. 219, No. 4587, 1983, pp. 979-980.
doi:10.1126/science.6823561
|
[7]
|
J. W. Langston, “MPTP Neurotoxicity: An Overview and Characterization of Phases of Toxicity,” Life Science, Vol. 36, No. 3, 1985, pp. 201-206.
doi:10.1016/0024-3205(85)90059-1
|
[8]
|
C. C. Chiueh, R. S. Burns, S. P. Markey, D. M. Jacobowitz and I. J. Kopin, “A Primate Model of Parkinsonism: Selective Destruction of Dopaminergic Neurons in the Pars Compacta of the Substantia Nigra by N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,” Life Science, Vol. 36, 1985, pp. 213-217.
|
[9]
|
J. W. Langston, L. S. Forno, C. S. Rebert and I. Irwin, “Selective Nigral Toxicity after Systemic Administration of 1-Methyl-4-phenyl-1,2,5,6-Tetrahydropyrine (MPTP) in the Squirrel Monkey,” British Research, Vol. 292, 1984, pp. 390-394.
|
[10]
|
J. E. Christie, A. Shering, J. Ferguson and A. I. M. Glen, “Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia,” The British Journal of Psychiatry, Vol. 138, 1981, pp. 46-50.
doi:10.1192/bjp.138.1.46
|
[11]
|
P. Sauerberg, J. J. Larsen, E. Falch and P. Krogsgaard-Larsen, “A Novel Class of Conformationally Restricted Heterocyclic Muscarinic Agonists,” Journal of Medicinal Chemistry, Vol. 29, No. 6, 1986, pp. 1004-1009.
doi:10.1021/jm00156a018
|
[12]
|
P. Sauerberg, B. Fjalland, J. J. Larsen, T. Bach-Lauritsen, E. Falch and P. Krogsgaard-Larsen, “Pharmacological Profile of a Novel Class of Muscarinic Acetylcholine Receptor Agonists,” European Journal of Pharmacology, Vol. 130, No. 1-2, 1986, pp. 125-131.
doi:10.1016/0014-2999(86)90191-3
|
[13]
|
P. Krogsgaard-Larsen, E. Falch, P. Sauerberg, S. B. Freedman, H. L. Lembùl and E. Meier, “In Subtypes of Muscarinic Receptors III,” Elsevier, Amsterdam, 1988, pp. 69-74.
|
[14]
|
P. Sauerberg, E. Falch, E. Meier, H. L. Lembùl and P. Krogsgaard-Larsen, “Heterocyclic Muscarinic Agonists. Synthesis and Biological Activity of Some Bicyclic Sulfonium Arecoline Bioisosteres,” Journal of Medicinal Chemistry, Vol. 31, No. 7, 1988, pp. 1312-1316.
doi:10.1021/jm00402a010
|
[15]
|
T. Ogamino and S. Nishiyama, “A New Ring-Opening Access to Aeroplysinin-1, a Secondary Metabolite of Verongia Aerophoba,” Tetrahedron, Vol. 59, 2003, pp. 9419- 9423.
|
[16]
|
G. Daidone, D. Raffa, B. Maggio, F. Plescia, V. M. C. Cutuli, N. G. Mangano and A. Caruso, “Synthesis and Antiproliferative Activity of Novel 3-(Indazol-3-yl)-qui- nazolin-4(3H)-one and 3-(Indazol-3-yl)-benzotriazin-4(3H)-one Derivatives,” Arch. Pharm. Med. Chem, Vol. 50, 1999, p. 332.
|
[17]
|
K. Tomita, Y. Takahi, R. Ishizuka, S. Kamamura, M. Nakagawa, M. Ando, T. Nakanishi, T. Nakamura and H. Udaira, Ann. Sankyo Res. Lab. Vol. 1, 1973, p. 25; Chem. Abstr. 1974, 80, 120808.
|
[18]
|
J. J. Talley, D. L. Brown, J. S. Carter, M. J. Graneto, C. M. Koboldt, J. L. Masferrer, W. E. Perkins, R. S. Rogers, A. F. Shaffer, Y. Y. Zhang, B. S. Zweifel and K. Seibert, “4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, Valdecoxib:? A Potent and Selective Inhibitor of COX-2,” Journal of Medicinal Chemistry, Vol. 43, 2000, pp. 775-777.
|
[19]
|
K. Haripara, S. Patel, A. Joshi and H. Parekh, “Synthesis and Biological Evaluation of Some Cyano Pyridines and Isoxazoles,” Indian J. Het. Chem, Vol. 13, 2004, pp. 221-224.
|
[20]
|
H. Uno, M. Kurokawa, Y. Masuda and H. Nishimura, “Studies on 3-Substituted 1,2-Benzisoxazole Derivatives. Syntheses of 3-(Sulfamoylmethyl)-1,2-Benzisoxazole Derivatives and Their Anticonvulsant Activities,” Journal of Medicinal Chemistry, Vol. 22, No. 2, 1979, pp. 180-183.
doi:10.1021/jm00188a011
|
[21]
|
W.-T. Li, D.-R. Hwang, C.-P. Chen, C.-W. Shen, C.-L. Huang, T.-W. Chen, C.-H. Lin, Y.-L. Chang, Y.-Y. Chang, Y.-K. Lo, H.-Y. Tseng, C.-C. Lin, J.-S. Song, H.-C. Chen, S.-J. Chen, S.-H. Wu and C.-T. Chen, “Synthesis and Biological Evaluation of N-Heterocyclic Indolyl Glyoxylamides as Orally Active Anticancer Agents,” Journal of Medicinal Chemistry, Vol. 46, No. 9, 2003, pp. 1706-1715. doi:10.1021/jm020471r
|
[22]
|
E. Rajanarendar, M. Nagi Reddy, K. Rama Murthy, K. Govardhan Reddy, S. Raju, M. Srinivas, B. Praveen and M. Srinivasa Rao, “Synthesis, Antimicrobial, and Mosquito Larvicidal Activity of 1-Aryl-4-Methyl-3,6-Bis- (5-Methylisoxazol-3-yl)-2-Thioxo-2,3,6,10b-Tetrahydro-1H-Pyrimido[5,4-c]quinolin-5-Ones,” Bioorganic & Medicinal Chemistry Letters, Vol. 20, No. 20, 2010, pp. 6052-6055. doi:10.1016/j.bmcl.2010.08.060
|
[23]
|
E. Rajanarendar, M. Nagi Reddy, S. Rama Krishna, K. Rama Murthy, P. Surendar, R. N. Reddy and Y. N. Reddy, “Synthesis and in Vitro and in Vivo Anticancer Activity of Novel Phenylmethylene Bis-isoxazolo[4,5-b]azepines,” Bioorganic & Medicinal Chemistry Letters, Vol. 22, No. 2012, pp. 149-153. doi:10.1016/j.bmcl.2011.11.044
|
[24]
|
E. Rajanarendar, S. Raju, M. Nagi Reddy, S. Rama Krishna, L. Hari Kiran, A. Ram Narasimha Reddy and Y Narasimha Reddy, “Multi-Component Synthesis and in Vitro and in Vivo Anticancer Activity of Novel Arylmethylene Bis-isoxazolo[4,5-b]pyridine-N-Oxides,” European Journal of Medicinal Chemistry, Vol. 50, 2012, pp. 274-279.
|
[25]
|
E. Rajanarendar, M. Nagi Reddy, S. Rama Krishna, K. Govardhan Reddy, Y. N. Reddy and M. V. Rajam, “Design, Synthesis, in Vitro Antimicrobial and Anticancer Activity of Novel Methylenebis-Isoxazolo[4,5-b]azepines Derivatives,” European Journal of Medicinal Chemistry, Vol. 50, 2012, pp. 344-349.
doi:10.1016/j.ejmech.2012.02.013
|
[26]
|
E. Rajanarendar, M. Nagi Reddy, K. Govardhan Reddy and S. Rama Krishna, “l-Proline Catalyzed Efficient One-Pot Three-Component Aza-Diels–Alder Reactions on Nitrostyrylisoxazoles: A Facile Synthesis of New Isoxazolyl Tetrahydroquinolines and Isoxazolo[2,3-a]pyrimidines,” Tetrahedron Letters, Vol. 53, No. 23, 2012, pp. 2909- 2913. doi:10.1016/j.tetlet.2012.04.002
|
[27]
|
M. Misra, S. K. Pandey, V. P. Pandey, J. Pandey, R. Tripathi, R. P. Tripathi, “Organocatalyzed Highly Atom Economic One Pot Synthesis of Tetrahydropyridines as Antimalarials,” Bioorganic & Medicinal Chemistry, Vol. 17, No. 2, 2009, pp. 625-633.
doi:10.1016/j.bmc.2008.11.062
|
[28]
|
A. T. Khan, T. Parvin and L. H. Choudhary, “Effects of Substituents in the β-Position of 1,3-Dicarbonyl Compounds in Bromodimethylsulfonium Bromide-Catalyzed Multicomponent Reactions: A Facile Access to Functionalized Piperidines,” The Journal of Organic Chemistry, Vol. 73, No. 1, 2008, pp. 8398-8402.
doi:10.1021/jo8014962
|
[29]
|
A. T. Khan, M. Lal and M. M. Khan, “Synthesis of Highly Functionalized Piperidines by One-Pot Multicomponent Reaction Using Tetrabutylammonium Tribromide (TBATB),” Tetrahedron Letters, Vol. 51, No. 33, 2010, pp. 4419-4424. doi:10.1016/j.tetlet.2010.06.069
|
[30]
|
A. T. Khan, M. M. Khan and K. R. B. Karthi, “Iodine Catalyzed One-Pot Five-Component Reactions for Direct Synthesis of Densely Functionalized Piperidines,” Tetra- hedron, Vol. 66, No. 39, 2010, pp. 7762-7772.
doi:10.1016/j.tet.2010.07.075
|
[31]
|
P. A. Clarke, P. A. Zaytzev and A. C. Whitwood, “Pot, Atom and Step Economic (PASE) Synthesis of Highly Functionalized Piperidines: A Five-Component Condensation,” Tetrahedron Letters, Vol. 48, No. 20, 2007, pp. 5209-5212. doi:10.1016/j.tetlet.2007.05.141
|
[32]
|
S. Mishra, R. Ghosh, “Efficient One-Pot Synthesis of Functionalized Piperidine Scaffolds via ZrOCl2?8H2O Catalyzed Tandem Reactions of Aromatic Aldehydes with Amines and Acetoacetic Esters,” Tetrahedron Letters, Vol. 52, No. 22, 2011, pp. 2857-2861.
doi:10.1016/j.tetlet.2011.03.116
|
[33]
|
W. Hong-Juan, M. Li-Ping and Z. Zhan-Hui, ACS Comb. Sci. Vol. 13, 2011, p. 181.
|
[34]
|
R. Kumar, P. Chaudhary, S. Nimesh, A. K. Verma and R. Chandra, “An Efficient Synthesis of 1,5-Benzadiazepine Derivatives Catalyzed by Silver Nitrate,” Green Chemistry, Vol. 8, No. 6, 2006, pp. 519-521.
doi:10.1039/b601993e
|
[35]
|
A. K. Verma, P. Attri, V. Chopra, R. K. Tiwari and R. Chandra, “Triethylammonium Acetate (TEAA): A Recy- clable Inexpensive Ionic Liquid Promotes the Chemoselective Aza-and Thia-Michael Reactions,” Monatsh Che- mistry, Vol. 139, 2008, p. 1041
|
[36]
|
C. Wang, L. Guo, H. Li, Y. Wang, J. Weng and L. Wu, “Preparation of Simple Ammonium Ionic Liquids and Their Application in the Cracking of Dialkoxypropanes,” Green Chemistry, Vol. 8, No. 7, 2006, pp. 603-607.
doi:10.1039/b600041j
|
[37]
|
J. Weng, C. Wang, H. Li, Y. Wang, “Novel Quaternary Ammonium Ionic Liquids and Their Use as Dual Solvent-Catalysts in the Hydrolytic Reaction,” Green Chemistry, Vol. 8, No. 1, 2006, pp. 96-99. doi:10.1039/b508325g
|
[38]
|
H. Jiang, C. Wang, H. Li and Y. Wang, “Preparation of Dialkoxypropanes in Simple Ammonium Ionic Liquids,” Green Chemistry, Vol. 8, No. 12, 2006, pp. 1076-1079.
doi:10.1039/b608249a
|